Thepaut Eric Francis Yves
SEC CIK 1631992 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | EVP, Pres, Eur, Mid-East, Afr | 44.4K | — | $8.67M | 39 | 2021-08-05 | 2024-05-10 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Thepaut Eric Francis Yves made no open-market trades at BSX in the last 12 months.
Transactions 39
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-13 | 2024-05-10 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $16.31 | +12.9K | 44.4K | +41% | +$210.9K |
| D | 2024-05-13 | 2024-05-10 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale+OE | $74.14 | -12.9K | 31.4K | -29% | -$958.7K |
| A | 2024-03-11 | 2024-02-14 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | — | 0 | 28.6K | New | — |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +4,763 | 30.6K | +18% | $0 |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $65.82 | -2,759 | 29.2K | -9% | -$181.6K |
| D | 2024-02-20 | 2024-02-18 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $65.82 | -1,160 | 30.0K | -4% | -$76.4K |
| D | 2024-02-20 | 2024-02-18 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +2,002 | 31.2K | +7% | $0 |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $65.95 | -1,378 | 27.2K | -5% | -$90.9K |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +2,379 | 28.6K | +9% | $0 |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $0.00 | -11.6K | 26.2K | -31% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | A - Grant | $0.00 | +20.0K | 37.8K | +113% | $0 | |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +13.1K | 25.3K | +107% | $0 |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $57.81 | -7,573 | 17.8K | -30% | -$437.8K |
| D | 2023-05-03 | 2023-05-02 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale+OE | $52.49 | -83.4K | 12.3K | -87% | -$4.38M |
| D | 2023-05-03 | 2023-05-02 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $12.89 | +30.7K | 95.7K | +47% | +$395.6K |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $46.23 | -993 | 65.0K | -2% | -$45.9K |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,714 | 66.0K | +3% | $0 |
| D | 2023-02-21 | 2023-02-18 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +2,001 | 65.4K | +3% | $0 |
| D | 2023-02-21 | 2023-02-18 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $46.54 | -1,159 | 64.3K | -2% | -$53.9K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $46.51 | -2,758 | 62.4K | -4% | -$128.3K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +4,762 | 63.7K | +8% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,846 | 62.5K | +3% | $0 |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $47.29 | -1,069 | 61.4K | -2% | -$50.6K |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +7,092 | 64.6K | +12% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $46.27 | -3,988 | 60.6K | -6% | -$184.5K |
| 2022-11-21 | 2022-11-18 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $42.72 | -15.0K | 57.5K | -21% | -$638.7K | |
| 2022-08-03 | 2022-08-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $40.99 | -20.7K | 72.5K | -22% | -$847.5K | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $44.17 | -1,031 | 93.2K | -1% | -$45.5K |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,833 | 94.2K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,714 | 93.3K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $42.55 | -964 | 92.4K | -1% | -$41.0K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $42.71 | -2,531 | 91.6K | -3% | -$108.1K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +4,501 | 92.1K | +5% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $44.01 | -1,038 | 89.6K | -1% | -$45.7K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,846 | 90.7K | +2% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +6,175 | 92.3K | +7% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $42.48 | -3,472 | 88.8K | -4% | -$147.5K |
| D | 2021-08-11 | 2021-08-10 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $13.08 | +20.0K | 86.1K | +30% | +$261.6K |
| 2021-08-06 | 2021-08-05 | BSX | Boston Scientific | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $44.14 | -41.7K | 66.1K | -39% | -$1.84M |
Purchase Sale Sale after option exercise All abbreviations